These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12864890)

  • 21. Indigenous disparities in disease-specific mortality, a cross-country comparison: New Zealand, Australia, Canada, and the United States.
    Bramley D; Hebert P; Jackson R; Chassin M
    N Z Med J; 2004 Dec; 117(1207):U1215. PubMed ID: 15608808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
    Foote C; Clayton PA; Johnson DW; Jardine M; Snelling P; Cass A
    Am J Kidney Dis; 2014 Sep; 64(3):359-66. PubMed ID: 24787762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
    Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
    Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients.
    Grace BS; Clayton P; Cass A; McDonald SP
    Nephrol Dial Transplant; 2012 Nov; 27(11):4173-80. PubMed ID: 22923546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal replacement therapy in rural and urban Australia.
    Gray NA; Dent H; McDonald SP
    Nephrol Dial Transplant; 2012 May; 27(5):2069-76. PubMed ID: 21984553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing reported rates of treated end-stage renal disease.
    McDonald S; McCredie M; Williams S; Stewart J
    Adv Chronic Kidney Dis; 2005 Jan; 12(1):32-8. PubMed ID: 15719331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA.
    Lim WH; Johnson DW; McDonald SP
    Nephrology (Carlton); 2005 Apr; 10(2):192-7. PubMed ID: 15877681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An expanded nationwide view of chronic kidney disease in Aboriginal Australians.
    Hoy WE; Mott SA; Mc Donald SP
    Nephrology (Carlton); 2016 Nov; 21(11):916-922. PubMed ID: 27075933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
    Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
    Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources.
    Li L; Guthridge S; Li SQ; Zhao Y; Lawton P; Cass A
    BMC Nephrol; 2018 Jan; 19(1):15. PubMed ID: 29334912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on chronic kidney disease in Aboriginal Australians.
    Hoy WE; Mott SA; McDonald SP
    Clin Nephrol; 2020; 93(1):124-128. PubMed ID: 31426912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease.
    White A; Wong W; Sureshkumur P; Singh G
    J Paediatr Child Health; 2010 Sep; 46(9):504-9. PubMed ID: 20854321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations.
    Marshall MR; Polkinghorne KR; Kerr PG; Hawley CM; Agar JW; McDonald SP
    Am J Kidney Dis; 2016 Apr; 67(4):617-28. PubMed ID: 26561355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality.
    Lim WH; Boudville N; McDonald SP; Gorham G; Johnson DW; Jose M
    Nephrol Dial Transplant; 2011 Oct; 26(10):3366-72. PubMed ID: 21382988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney transplant outcomes in the indigenous population in the Northern Territory of Australia.
    Rogers NM; Lawton PD; Jose MD
    Transplantation; 2006 Oct; 82(7):882-6. PubMed ID: 17038901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the United States: a systematic scoping review.
    Katzenellenbogen JM; Woods JA; Teng TH; Thompson SC
    BMC Cardiovasc Disord; 2015 Aug; 15():87. PubMed ID: 26268309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):247-52. PubMed ID: 15363057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.